Variant report
Variant | nsv981024 |
---|---|
Chromosome Location | chr5:96992487-96996964 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559157409 | chr5:96992857-96992858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577647391 | chr5:96992903-96992904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544639139 | chr5:96992925-96992926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187369685 | chr5:96992940-96992941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367896840 | chr5:96992957-96992958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530764205 | chr5:96992964-96992965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386690305 | chr5:96992969-96992970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201277945 | chr5:96992971-96992972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6556995 | chr5:96992975-96992976 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs560760382 | chr5:96993003-96993004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142585852 | chr5:96993011-96993012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192333088 | chr5:96993059-96993060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17087681 | chr5:96993093-96993094 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs539104053 | chr5:96993101-96993102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183331119 | chr5:96993111-96993112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569270952 | chr5:96993214-96993215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187758634 | chr5:96993294-96993295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77726451 | chr5:96993327-96993328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573407795 | chr5:96993363-96993364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534158394 | chr5:96993402-96993403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559092114 | chr5:96993410-96993411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs34654313 | chr5:96993462-96993463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192433249 | chr5:96993502-96993503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113810155 | chr5:96993505-96993506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562951608 | chr5:96993529-96993530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574854209 | chr5:96993587-96993588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542530691 | chr5:96993619-96993620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560994703 | chr5:96993644-96993645 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75378083 | chr5:96993737-96993738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546509625 | chr5:96993770-96993771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565079034 | chr5:96993814-96993815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57472041 | chr5:96993817-96993818 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs551047942 | chr5:96993819-96993820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184826802 | chr5:96993822-96993823 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569282554 | chr5:96993919-96993920 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs566892358 | chr5:96993993-96993994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536613865 | chr5:96993994-96993995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112271619 | chr5:96994029-96994030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567087801 | chr5:96994069-96994070 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539924384 | chr5:96994146-96994147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375496250 | chr5:96994150-96994151 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150094160 | chr5:96994201-96994202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373363968 | chr5:96994254-96994255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577323711 | chr5:96994276-96994277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538359317 | chr5:96994322-96994323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556606447 | chr5:96994334-96994335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574917491 | chr5:96994363-96994364 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138398895 | chr5:96994369-96994370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554532176 | chr5:96994375-96994376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200667117 | chr5:96994397-96994398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:96992800-96994800 | Enhancers | HUVEC | blood vessel |
2 | chr5:96993000-96993400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr5:96993000-96993600 | Enhancers | Adipose Nuclei | Adipose |
4 | chr5:96993000-96994600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:96993400-96993800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr5:96993600-96994600 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr5:96993800-96994400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr5:96993800-96994400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr5:96994000-96994400 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr5:96994000-96994600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr5:96994000-96996600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr5:96994200-96994600 | Enhancers | Liver | Liver |
13 | chr5:96994600-96994800 | Enhancers | Adipose Nuclei | Adipose |